{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:22:07Z","timestamp":1740122527075,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11239-019-01824-x","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T01:24:18Z","timestamp":1549502658000},"page":"384-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Shorter hospital stays in epistaxis patients with atrial fibrillation when taking rivaroxaban or apixaban versus phenprocoumon"],"prefix":"10.1007","volume":"47","author":[{"given":"Petar","family":"Stankovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Georgiew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Frommelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wittlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Obradovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Dagres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-5224","authenticated-orcid":false,"given":"Thomas","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"issue":"5","key":"1824_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1749-4486.2007.01530.x","volume":"32","author":"T Walker","year":"2007","unstructured":"Walker T, Macfarlane T, McGarry G (2007) The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995\u20132004. Clin Otolaryngol 32(5):361\u2013365","journal-title":"Clin Otolaryngol"},{"key":"1824_CR2","unstructured":"Destatis. Diagnosedaten der Krankenh\u00e4user ab 2000 (Eckdaten der vollstation\u00e4ren Patienten und Patientinnen) (2018) Gesundheitsberichterstattung des Bundes. \n                    http:\/\/www.gbe-bund.de\/"},{"key":"1824_CR3","unstructured":"Statistics NHe (2016) \n                    http:\/\/content.digital.nhs.uk\/hes"},{"key":"1824_CR4","unstructured":"Destatis (2015) Sterbef\u00e4lle, Sterbeziffern (je 100.000 Einwohner, altersstandardisiert). \n                    http:\/\/www.gbe-bund.de\/"},{"issue":"46","key":"1824_CR5","first-page":"3238","volume":"36","author":"F Andreotti","year":"2015","unstructured":"Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M et al (2015) Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J 36(46):3238\u20133249","journal-title":"Eur Heart J"},{"issue":"4","key":"1824_CR6","first-page":"249","volume":"93","author":"C Bermuller","year":"2014","unstructured":"Bermuller C, Bender M, Brogger C, Petereit F, Schulz M (2014) Epistaxis and anticoagulation\u2014a medical and economic challenge?. Laryngorhinootologie 93(4):249\u2013255","journal-title":"Laryngorhinootologie"},{"issue":"5","key":"1824_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1017\/S0022215113000492","volume":"127","author":"TC Biggs","year":"2013","unstructured":"Biggs TC, Baruah P, Mainwaring J, Harries PG, Salib RJ (2013) Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients. J Laryngol Otol 127(5):483\u2013488","journal-title":"J Laryngol Otol"},{"issue":"12","key":"1824_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1017\/S002221511700202X","volume":"131","author":"INTEGRATE","year":"2017","unstructured":"INTEGRATE (2017) Epistaxis 2016: national audit of management. J Laryngol Otol 131(12):1131\u20131141","journal-title":"J Laryngol Otol"},{"issue":"12","key":"1824_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/S0022215110001921","volume":"125","author":"J Smith","year":"2011","unstructured":"Smith J, Siddiq S, Dyer C, Rainsbury J, Kim D (2011) Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study. J Laryngol Otol 125(12):38\u201342","journal-title":"J Laryngol Otol"},{"key":"1824_CR10","unstructured":"FDA (2010) Approval Dabigatran. \n                    https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022512orig1s000toc.cfm"},{"key":"1824_CR11","unstructured":"FDA (2011) Approval Rivaroxaban. \n                    https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2011\/202439s000ltr.pdf"},{"key":"1824_CR12","unstructured":"FDA (2012) Approval Apixaban. \n                    https:\/\/www.fda.gov\/downloads\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm333723.pdf"},{"issue":"8","key":"1824_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","volume":"132","author":"A Avezum","year":"2015","unstructured":"Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M et al (2015) Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation 132(8):624\u2013632","journal-title":"Circulation"},{"issue":"10","key":"1824_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, HackeW et al (2011) Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation. New Engl J Med 365(10):883\u2013891","journal-title":"New Engl J Med"},{"issue":"4","key":"1824_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4193\/Rhin16.040","volume":"54","author":"KM Musgrave","year":"2016","unstructured":"Musgrave KM, Powell J (2016) A systematic review of anti-thrombotic therapy in epistaxis. Rhinology 54(4):292\u2013301","journal-title":"Rhinology"},{"issue":"1","key":"1824_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/coa.12904","volume":"43","author":"TC Sauter","year":"2018","unstructured":"Sauter TC, Hegazy K, Hautz WE, Krummrey G, Ricklin ME, Nagler M et al (2018) Epistaxis in anticoagulated patients: fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon. Clin Otolaryngol 43(1):103\u2013108","journal-title":"Clin Otolaryngol"},{"issue":"6","key":"1824_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.otorri.2014.02.014","volume":"65","author":"FJ Garc\u00eda Callejo","year":"2014","unstructured":"Garc\u00eda Callejo FJ, B\u00e9cares Mart\u00ednez C, Calvo Gonz\u00e1lez J, Mart\u00ednez Beneyto P, Marco Sanz M, Marco Algarra J (2014) Epistaxis and dabigatran, a new non-vitamin K antagonist oral anticoagulant. Acta Otorrinolaringol Esp 65(6):346\u2013354","journal-title":"Acta Otorrinolaringol Esp"},{"issue":"31\u201332","key":"1824_CR18","first-page":"523","volume":"110","author":"K Werdan","year":"2013","unstructured":"Werdan K, Braun-Dullaeus R, Presek P (2013) Anticoagulation in atrial fibrillation: NOAC\u2019s the word. Dtsch Arztebl Int 110(31\u201332):523\u2013524","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"1824_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263\u2013272","journal-title":"Chest"},{"issue":"5","key":"1824_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093\u20131100","journal-title":"Chest"},{"issue":"21","key":"1824_CR21","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719\u20132747","journal-title":"Eur Heart J"},{"issue":"2","key":"1824_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315\u2013352","journal-title":"Chest"},{"issue":"11","key":"1824_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981\u2013992","journal-title":"N Engl J Med"},{"issue":"3","key":"1824_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/0194599817705619","volume":"157","author":"O Cohen","year":"2017","unstructured":"Cohen O, Shoffel-Havakuk H, Warman M, Tzelnick S, Haimovich Y, Kohlberg GD et al (2017) Early and late recurrent epistaxis admissions: patterns of incidence and risk factors. Otolaryngol Head Neck Surg 157(3):424\u2013431","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01824-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:18:33Z","timestamp":1581016713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01824-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01824-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"7 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have indicated that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}